Skip to main content

EDITORIAL article

Front. Psychiatry, 27 November 2023
Sec. Psychopathology
This article is part of the Research Topic Advances of Neurobiological Basis and Psychopathological Mechanism for Mood Disorders View all 4 articles

Editorial: Advances of neurobiological basis and psychopathological mechanism for mood disorders

  • 1Department of Radiology, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
  • 2Key Laboratory of Molecular Biophysics of the Ministry of Education, College of Life Science and Technology and Center for Human Genome Research, Huazhong University of Science and Technology, Wuhan, China
  • 3Second Affiliated Hospital of Jilin University, Changchun, China
  • 4School of Medicine, Indiana University Bloomington, Indianapolis, IN, United States
  • 5Normal College, Qingdao University, Qingdao, Shandong, China

Mental disorders are a group of diseases that are characterized by cognitive, emotional, and behavioral disturbances, affecting over 450 million people worldwide (1). They not only seriously threaten people's health and lives but also impose negative social and economic consequences (2). Mood disorders are one of the most common types of mental disorders in the world, and their prevalence continues to rise, particularly during the COVID-19 pandemic (3). However, the neurobiological basis and psychopathological mechanisms of mood disorders have not been fully explained, which limits the establishment of therapeutic strategies. Therefore, in this Research Topic, we focused on the latest advancements in the neurobiological basis, psychopathological mechanism, and diagnostic strategies of mood disorder, which may explain the cause of mood disorders and provide a theoretical basis for clinical interventions.

Deficits in attentional control are an important factor influencing depressive mood development. Heart rate variability (HRV) is considered to be a psychophysiological marker, which is regulated by the interaction of the vagal and sympathetic components of the autonomic nervous system and indirectly, objectively, and reliably reflects the functioning of the autonomic nervous system (4). It is defined as the variability of the interval between successive heartbeats, and the measurement is feasible and reliable. Zheng et al. conducted a cross-sectional study with 220 college students to verify whether gender moderates the relationship between attentional control and resting vaguely mediated HRV (vmHRV). Results found that women have worse attentional shifting abilities and higher resting vmHRV than men. Attentional shifting facilitates the way people shift their attention away from negative thoughts and information. Higher resting vmHRV in women reflects a compensatory response to deficits in attentional control. These results help explain why it is easier for women to become depressed and provide neurophysiological evidence to elucidate gender differences in attentional control.

Psychophysiological biomarkers are considered more objective metrics in the diagnosis of mood disorders. Ham et al. examined the link between the self-rated questionnaire and the clinician-rated assessments, and HRV indices in patients with depressive and anxious symptoms. They observed that HRV variables showed significant associations only with the clinician-rated assessments. Furthermore, a stronger relationship was observed between depression and HRV indices; the severity of depressive symptoms could be objectively assessed through the HRV indices.

Recently, neuroimaging has emerged as a valuable method for investigating the pathogenesis of mood disorders. Functional MRI (fMRI) based on blood oxygenation level-dependent signals fractional amplitude of low-frequency fluctuation (fALFF) can be used to detect neural activity during the resting state (5). Zhang et al. conducted a study to investigate the influence of sleep disturbances (SD) on clinical characteristics of major depressive disorder (MDD) patients, using resting-state fMRI (rs-fMRI). They observed that both MDD patients without SD symptoms (Pa_s) and patients with SD symptoms (Pa_ns) displayed abnormal fALFF in the frontal-occipital brain regions, suggesting that this is a common characteristic of MDD patients. In addition, the author found Pa_s showed a higher fALFF value in the left precuneus compared with Pa_ns, which could be used to distinguish MDD patients with or without SD symptoms. These results suggest a higher fALFF value in the left precuneus could be a specific neuroimaging characteristic differentiating the two groups in clinical practice. However, due to the small sample size, these results should be interpreted with caution and need to be validated in distinct SD performance.

Collectively, the articles collected on this topic included studies on neurophysiological mechanisms and psychophysiological and early imaging change markers for mood disorders. Recently, new promising technologies have been emerging, especially artificial intelligence and genomics. Future studies should continue to discover more specific biomarkers that may expand the understanding of mood disorders and examine the effects of interventions targeting these biomarkers for mood disorders.

Author contributions

YD: Writing—original draft. YL: Writing—original draft. CX: Supervision, Validation, Writing—review & editing. RC: Writing—review & editing. Y-YM: Writing—review & editing. HW: Writing—review & editing. XX: Supervision, Validation, Writing—review & editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Babicki M, Małecka M, Kowalski K, Bogudzińska B, Piotrowski P. Stigma levels toward psychiatric patients among medical students-a worldwide online survey across 65 countries. Front Psychiatry. (2021) 12:798909. doi: 10.3389/fpsyt.2021.798909

PubMed Abstract | CrossRef Full Text | Google Scholar

2. GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. (2020) 396:1223–49. doi: 10.1016/S0140-6736(20)30752-2

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Kaggwa MM, Arinaitwe I, Nduhuura E, Muwanguzi M, Kajjimu J, Kule M, et al. Prevalence and factors associated with depression and suicidal ideation during the COVID-19 pandemic among university students in uganda: a cross-sectional study. Front Psychiatry. (2022) 13:842466. doi: 10.3389/fpsyt.2022.842466

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Bertsch K, Hagemann D, Naumann E, Schächinger H, Schulz A. Stability of heart rate variability indices reflecting parasympathetic activity. Psychophysiology. (2012) 49:672–82. doi: 10.1111/j.1469-8986.2011.01341.x

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Zhuo C, Li G, Lin X, Jiang D, Xu Y, Tian H, et al. The rise and fall of MRI studies in major depressive disorder. Transl Psychiatry. (2019) 9:335. doi: 10.1038/s41398-019-0680-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: mood disorders, psychopathological mechanisms, heart rate variability, neurobiological, biomarkers

Citation: Dong Y, Liu Y, Xu C, Cui R, Ma Y-Y, Wei H and Xu X (2023) Editorial: Advances of neurobiological basis and psychopathological mechanism for mood disorders. Front. Psychiatry 14:1333775. doi: 10.3389/fpsyt.2023.1333775

Received: 06 November 2023; Accepted: 14 November 2023;
Published: 27 November 2023.

Edited and reviewed by: Xavier Noel, Université Libre de Bruxelles, Belgium

Copyright © 2023 Dong, Liu, Xu, Cui, Ma, Wei and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiangyang Xu, 1993ly0538@hust.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.